Retractable Technologies (NYSE:RVP) Now Covered by StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research note published on Tuesday. The firm issued a hold rating on the stock.

Retractable Technologies Stock Performance

Shares of RVP opened at $0.63 on Tuesday. Retractable Technologies has a 12-month low of $0.56 and a 12-month high of $1.34. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. The business’s fifty day moving average price is $0.74 and its 200 day moving average price is $0.95. The stock has a market capitalization of $18.72 million, a PE ratio of -1.16 and a beta of 2.06.

Insiders Place Their Bets

In other Retractable Technologies news, CEO Thomas J. Shaw purchased 71,422 shares of the stock in a transaction dated Friday, September 20th. The shares were bought at an average cost of $0.82 per share, with a total value of $58,566.04. Following the completion of the acquisition, the chief executive officer now owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. This trade represents a 0.49 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have purchased 179,649 shares of company stock valued at $143,163 over the last three months. Company insiders own 55.00% of the company’s stock.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new stake in Retractable Technologies, Inc. (NYSE:RVP) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is owned by institutional investors and hedge funds.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.